Articleresearch

Intermittent Fasting Reduces Insulin Resistance and Improves Hormone Profiles in Women with PCOS: What the Research Shows

A 2025 meta-analysis in Nutrients (PMID 40806019) found IF significantly reduced HOMA-IR by 0.94, lowered insulin 3.17 μU/mL, and raised SHBG in women with PCOS.

FastingInPractice Editors

Intermittent Fasting Reduces Insulin Resistance and Improves Hormone Profiles in Women with PCOS: What the Research Shows

Medical disclaimer: This article summarises published research for informational purposes only. It is not medical advice and is not a substitute for guidance from a qualified health professional. Always consult your doctor before starting any fasting protocol, especially if you have an existing health condition or take medication.

Study at a Glance

TitleEffect of Intermittent Fasting on Anthropometric Measurements, Metabolic Profile, and Hormones in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
JournalNutrients
PublishedJuly 2025
Study typeSystematic review and meta-analysis of clinical studies
Total participantsWomen with PCOS across multiple pooled studies
Protocols studied8-hour time-restricted eating (TRF), 16:8 IF, 5:2 IF, and other IF protocols
Lead researcherYazan Ranneh
InstitutionDepartment of Nutrition and Dietetics, Al-Ain University, United Arab Emirates
FundingNot reported
SourceView on PubMed →

What This Study Looked At

Polycystic ovary syndrome (PCOS) affects roughly 1 in 10 women of reproductive age and is characterised by insulin resistance, elevated androgens, irregular periods, and difficulty losing weight. Standard management relies on medication and general dietary advice — but researchers have increasingly asked whether intermittent fasting (IF) might directly address the hormonal and metabolic root causes of the condition. This 2025 meta-analysis, published in the journal Nutrients, pooled data from multiple clinical studies to quantify the effects of various IF protocols on anthropometric measurements, metabolic markers, and reproductive hormones in women with confirmed PCOS diagnoses. For context on how insulin and hormone imbalances interact in PCOS, see our overview of intermittent fasting and insulin sensitivity and our article on intermittent fasting and PCOS.


Who Was Studied

GroupParticipantsWhat They Did
IF interventionWomen with PCOSVarious intermittent fasting protocols (8-hour TRF / 16:8 / 5:2) for 5–12 weeks
ComparisonWomen with PCOSCalorie-restricted diet, standard care, or no dietary change

Participant profile: Women of reproductive age with confirmed PCOS diagnoses (typically diagnosed via the Rotterdam criteria: two of three criteria — irregular periods, elevated androgens, or polycystic ovaries on ultrasound). The included studies recruited women ranging from approximately 18 to 40 years of age, with varying degrees of overweight or obesity.

How the fasting protocols worked in these studies: Most studies used an 8-hour eating window (16:8), with some using a 5:2 protocol (two days of significant calorie restriction per week). Participants ate normally within the specified eating window and fasted — consuming only water, plain tea, or coffee — outside it. Study durations ranged from approximately 5 to 12 weeks.


What the Researchers Found

Body Weight and Composition

OutcomeMean Difference95% CIp-value
Body weight−4.25 kg−7.71 to −0.790.02
BMI−2.05 kg/m²−3.26 to −0.850.0008
  • Women with PCOS who followed an IF protocol lost an average of 4.25 kg more than comparison groups, a statistically significant and clinically meaningful difference.
  • BMI dropped by a mean of 2.05 kg/m² — reflecting genuine fat loss rather than water weight fluctuation.

Insulin Resistance and Blood Sugar

OutcomeMean Difference95% CIp-value
Fasting insulin (μU/mL)−3.17−5.18 to −1.160.002
HOMA-IR−0.94−1.39 to −0.50<0.0001
  • HOMA-IR (a key measure of insulin resistance) dropped by 0.94 points — a substantial improvement. In women with PCOS, where insulin resistance is a central driver of the condition, this is clinically significant.
  • Fasting insulin fell by 3.17 μU/mL, indicating the body's cells were responding better to insulin signals.

Hormonal Profile

OutcomeStandardised Mean Difference95% CIp-value
SHBG (sex hormone binding globulin)+0.50 SMD+0.22 to +0.770.004
DHEA-S−33.21 μg/dL−57.29 to −9.130.007
Free androgen index (FAI)−1.61%−2.76 to −0.450.006
  • SHBG increased significantly (+0.50 SMD). SHBG binds free testosterone, reducing androgen activity — this is one of the most important hormonal changes in PCOS management.
  • DHEA-S (another androgen marker) fell by 33.21 μg/dL, indicating reduced androgenic activity across the body.
  • The Free Androgen Index (FAI), which measures the ratio of testosterone to SHBG, improved by 1.61%.

Lipid Profile

OutcomeMean Difference95% CIp-value
Triglycerides−40.71 mg/dL−61.53 to −19.900.0001
  • Triglycerides dropped by an average of 40.71 mg/dL — a major cardiovascular benefit, particularly important given that women with PCOS have elevated cardiovascular disease risk.

What Did Not Change Significantly

  • Waist-to-hip ratio (WHR)
  • Total cholesterol
  • LDL cholesterol
  • HDL cholesterol
  • Total testosterone levels
  • Anti-Müllerian hormone (AMH)

The absence of change in total testosterone is notable — the beneficial hormonal effect appears to operate through increasing SHBG (which binds and deactivates testosterone) rather than directly suppressing testosterone production.


What the Researchers Concluded

Intermittent fasting represents a promising dietary strategy for women with PCOS, producing significant improvements in body weight, insulin resistance, androgen markers, and triglycerides. The researchers noted, however, that the existing evidence remains preliminary and that further large-scale, well-controlled randomised trials are needed to confirm these findings and establish optimal protocols.


What This Means If You Fast

  • Insulin resistance is the core problem in most PCOS cases. IF directly targets insulin levels by keeping them low for extended daily periods. The HOMA-IR reduction of nearly 1 full point found in this meta-analysis represents meaningful improvement in a system that drives much of PCOS's hormonal dysfunction.
  • The SHBG rise is significant for symptoms. Higher SHBG means more of your testosterone is bound and inactive — this can reduce symptoms like acne, excess hair growth, and oily skin over weeks to months of consistent fasting.
  • Weight loss of 4+ kg is meaningful at scale. Even a 5–10% reduction in body weight in women with PCOS is associated with restored menstrual cycles and improved fertility outcomes in clinical literature.
  • Triglyceride reduction by 40+ mg/dL matters for long-term health. Women with PCOS are at higher cardiovascular risk; a triglyceride drop of this magnitude is a meaningful protective effect.
  • IF may work best alongside cycle-aware timing. Hormonal protocols that vary fasting length by menstrual phase — longer fasts in the follicular phase, shorter in the luteal phase — may optimise results while protecting progesterone. See our guide on how intermittent fasting affects women's hormones and intermittent fasting and PCOS research.
  • Results are not immediate. Most studies showing significant improvements ran for 5–12 weeks. Expect meaningful metabolic changes to emerge after 6–8 weeks of consistent practice.

Study Limitations

  • The overall evidence base for IF specifically in PCOS is still developing; individual included studies tend to have small sample sizes
  • Studies varied in IF protocol type, eating window hours, duration, and control conditions — pooling heterogeneous approaches introduces variability
  • Many studies lack long-term follow-up beyond 12 weeks — it is not yet known whether improvements are maintained for months or years
  • The majority of study participants were overweight or obese; results may not apply equally to lean women with PCOS
  • No significant changes in LDL, HDL, total cholesterol, or AMH — some hoped-for effects remain unconfirmed
  • Most studies are from China, Turkey, and Iran; population generalisability is uncertain
  • The systematic search ended April 2024, so more recent studies are not captured

Source

Ranneh, Y., Hamsho, M., Shkorfu, W., Terzi, M., & Fadel, A. (2025). Effect of intermittent fasting on anthropometric measurements, metabolic profile, and hormones in women with polycystic ovary syndrome: A systematic review and meta-analysis. Nutrients, 17(15), 2436. https://doi.org/10.3390/nu17152436. PMID: 40806019


Frequently Asked Questions

Does intermittent fasting work for PCOS weight loss?

This meta-analysis found IF produced an average of 4.25 kg more weight loss than comparison conditions in women with PCOS — a statistically significant result. Weight loss in PCOS is notoriously difficult due to insulin resistance, and the evidence suggests IF directly addresses that mechanism.

How long does it take for intermittent fasting to improve PCOS symptoms?

The studies included in this meta-analysis typically ran 5–12 weeks. Measurable improvements in insulin resistance and hormone markers appeared within this timeframe, though individual results vary. Allow at least 8 weeks of consistent practice before assessing results.

Will intermittent fasting reduce my testosterone if I have PCOS?

This meta-analysis found no significant reduction in total testosterone from IF. However, it did find a significant increase in SHBG (the protein that binds and deactivates testosterone) and a reduction in the Free Androgen Index — meaning less free, active testosterone was circulating even if total testosterone didn't fall.

Which type of intermittent fasting is best for PCOS?

The meta-analysis pooled data from 16:8, 8-hour TRF, 5:2, and other IF protocols. The evidence is not yet strong enough to recommend one protocol over another for PCOS. Most of the best-studied individual trials used 8-hour TRF (eating from approximately 10am–6pm or 12pm–8pm).

Can intermittent fasting help with PCOS-related irregular periods?

Several individual studies included in this review and others report improvements in menstrual regularity in women with PCOS following IF — with some studies showing 65–78% of participants experiencing restored or improved cycles within 8–12 weeks. The mechanism is likely through improved insulin sensitivity, which reduces androgen production from the ovaries.


Related Research and Articles


Want the complete guide to fasting? Get Intermittent Fasting in Practice on Amazon — and claim 3 months free on our fasting app at fastinginpractice.com/redeem.

📗

Want the complete guide?

Intermittent Fasting in Practice

Everything in this article — and hundreds more pages of practical guidance, protocols, recipes, and mindset strategies — is covered in depth in the book, available now on Amazon.

💬

Have personal experience with this? Your story helps thousands of people.